Navigation Links
Pharmasset Reports First Fiscal Quarter 2008 Financial Results
Date:2/14/2008

s with the Securities and Exchange Commission.

PHARMASSET, INC.

STATEMENTS OF OPERATIONS AND COMPREHENSIVE NET INCOME (LOSS)

(UNAUDITED)

Three Months Ended

December 31,

------------------------------

2007 2006

------------------------------

REVENUES $464,291 $8,116,584

------------------------------

COSTS AND EXPENSES:

Research and development 10,550,371 2,561,485

General and administrative 2,619,745 2,055,038

------------------------------

Total costs and expenses 13,170,116 4,616,523

------------------------------

OPERATING INCOME (LOSS) (12,705,825) 3,500,061

INVESTMENT INCOME 896,402 408,986

INTEREST EXPENSE (363,176) (1,841)

------------------------------

INCOME (LOSS) BEFORE INCOME TAXES (12,172,599) 3,907,206

PROVISION FOR INCOME TAXES - -

------------------------------

NET INCOME (LOSS) (12,172,599) 3,907,206

REDEEMABLE PREFERRED STOCK

ACCRETION - 284,197

----
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
2. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
3. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
4. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
5. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
6. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
7. CEL-SCI Corporation Reports First Quarter Financial Results
8. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
9. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
10. Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes
11. Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2008)...creased information density, automation and intell...cy in ultrasound to an all new level , , CH...emens Healthcare ( www.siemens.com/healthcare )... Volume Scanner (ABVS)(1), the world,s first mult...at the 94th Scientific Assembly and Annual Meeting...
(Date:11/25/2008)...mptom awareness can improve recovery , , Au...y are available on the Mayo Clinic News Blog. Plea... , , ROCHESTER, Minn., Nov. 25 /PRNewswire...ty of stroke patients don,t think they,re having a...ent until their condition worsens. The findings ap...
(Date:11/25/2008)...sults reveal most respondents against expanding st... , LITTLE FALLS, N.J., Nov. 25 /PRNewswire/ ...in may lower the cardiovascular risk of healthy pa...sal statin use in older adults, according to a nat...1,212 participants took part in the online poll co...
(Date:11/25/2008)...UTH SAN FRANCISCO, Calif., Nov. 25 /PRNewswire-Fir... PARD ), a biopharmaceutical company focused on,...at it will be exploring,strategic alternatives fo...low,the Company to focus its resources on the cli... candidate, and to support the initial commerciali...
Breaking Medicine Technology:Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Study questions impact of hemoglobin variations on mortality in dialysis patients 7637 1Study questions impact of hemoglobin variations on mortality in dialysis patients 7637 2Survey Shows Broad Support Among Americans for Pharmacy Technician Certification 7632 1Survey Shows Broad Support Among Americans for Pharmacy Technician Certification 7632 2Managing the Service to Sales Cultural Transformation Complimentary Excerpt Available from Best Practices 7627 1Managing the Service to Sales Cultural Transformation Complimentary Excerpt Available from Best Practices 7627 2Escape the Cold and Flu Season With a Free Vacation to the Sunshine State 7622 1Escape the Cold and Flu Season With a Free Vacation to the Sunshine State 7622 2
...ically effective in a,mouse model of Chronic Lymph...taris Pharma, the Danish,biopharmaceutical company...aging data at the American Association for Cancer,...at SPC2996, the,Company,s RNA Antagonist of Bcl-2,...of human Chronic Lymphocytic Leukaemia (CLL). , In...
...for Cancer Research Annual,Meeting, SAN DIEGO, Apr...rmaceuticals, Inc. , a biopharmaceutical research ... proprietary product,candidates for the treatment ... positive results from preclinical studies using a...Factor(R)) at the,American Association for Cancer ...
Other Medicine Technology:Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 2Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 3Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 4Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 5Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 6Adventrx Announces Positive Data From Multidrug Therapy With,CoFactor 2Adventrx Announces Positive Data From Multidrug Therapy With,CoFactor 3Adventrx Announces Positive Data From Multidrug Therapy With,CoFactor 4
(Date:12/1/2008)...heir DNA is damaged, in a process known as cellula...ading to unregulated cell division and therefore c...k,s issue of PLoS Biology , has found that when t...their surrounding environment. This causes inflamm...lopment of age-related diseases including, ironica...
(Date:12/1/2008)... Sloan-Kettering Cancer Center, New York, have dev...f genes for therapeutic purposes, and used this to... Small, noncoding RNA molecules known as miRNAs ar...In the study, the miRNA miR-181a was harnessed to ...n as T cells at different stages of their developm...
(Date:12/1/2008)...Westaim Corporation today announced it has requisi...T Pharmaceuticals Corp. to consider a return of ca...15 million or US$0.80 per share. Westaim will cont...of its 74.5 per cent stake in NUCRYST. Under the A...of Directors has 20 days to call a meeting of shar...
(Date:12/1/2008)...repreneur, television and,radio host Ryan Seacres...,Bendheim will be honored by the Cedars-Sinai Boa...Gala, December 2, 2008, at the Hyatt Regency Centu...rd of Governors, co-chairs the,event with Debbee ...e "Road To,A Cure" Gala is sponsored by Lexus, wh...
Breaking Medicine News(10 mins):Health News:Escape cancer, but age sooner? The dark side of the tumor suppressing process 2Health News:The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders 2Health News:Cedars-Sinai Board of Governors to Honor Ryan Seacrest & John Bendheim at Annual 'Road To A Cure' Gala 2
...a, which is a common problem for breast cancer pat... swelling, most often in the arms or legs, and dev...g, impaired, damaged, or removed. Secondary lymphe...ery, scar tissue formation, trauma,// deep vein th...
...rch has shown that those who smoke face the highes...non-smokers respectively. However, researchers add...causal path can be established. A study of cross-s...hold Survey on Drug Abuse(collected from different...
...rs have found that children who complain that they... a diagnosis that can be easily missed. They said ...ight time behaviours and who do not have a family ... of the disease called stationary night// blindnes...
...for potential medical problems, according to earli...n for adults. The rates for babies in hospitals ar...an Academy of Pediatrics (AAP) and the Agency for ... may help prevent medical errors in children.// Th...
Other Medicine News:
Our electronic charts include a Patient Face Sheet, summarizing patient information and as many as six custom tabs, so you can customize which information is important for you to document. In additio
...mprises the core applications for health informati...onic medical record. The suite includes applicatio...ncy completion & release of information., Imp...nment, CHARMS 2000 modules leverage the most sophi...
Clinician's Desktop provides users the tools needed to coordinate information. Utilizing client/server technology Clinicians Desktop provides users with electronic medical records.
...le is a PDA medical software for patient tracking,...r Pocket PC PDA. With CPT codes and cross-linked I...ing, it will make your patient tracking, charge ca...ut-patient or in-patient environment. This PDA med...
Medicine Products: